Published in Eur J Clin Microbiol Infect Dis on December 01, 2006
Prevalence of the ica operon and insertion sequence IS256 among Staphylococcus epidermidis prosthetic joint infection isolates. Eur J Clin Microbiol Infect Dis (2008) 1.00
Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model. Infect Immun (2014) 1.00
Structural basis of Staphylococcus epidermidis biofilm formation: mechanisms and molecular interactions. Front Cell Infect Microbiol (2015) 0.90
Diversity of antibiotic resistance genes and staphylococcal cassette chromosome mec elements in faecal isolates of coagulase-negative staphylococci from Nigeria. BMC Microbiol (2014) 0.87
Versatility of Biofilm Matrix Molecules in Staphylococcus epidermidis Clinical Isolates and Importance of Polysaccharide Intercellular Adhesin Expression during High Shear Stress. mSphere (2016) 0.82
Strong slime production is a marker of clinical significance in Staphylococcus epidermidis isolated from intravascular catheters. Eur J Clin Microbiol Infect Dis (2007) 0.80
Analysis of S. Epidermidis icaA and icaD genes by polymerase chain reaction and slime production: a case control study. BMC Infect Dis (2013) 0.76
Number of positive blood cultures, biofilm formation, and adhesin genes in differentiating true coagulase-negative staphylococci bacteremia from contamination. Eur J Clin Microbiol Infect Dis (2016) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol (1985) 10.22
Biofilms: microbial life on surfaces. Emerg Infect Dis (2002) 7.57
Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol (2003) 7.29
The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun (1999) 7.22
Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol (1996) 7.16
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev (1997) 6.98
Genetic approaches to study of biofilms. Methods Enzymol (1999) 6.78
Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol (1997) 5.47
Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis (2001) 4.94
Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb Drug Resist (2000) 4.24
Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun (1996) 3.95
Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis (1994) 3.88
A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol (1999) 3.48
Staphylococcus epidermidis infections. Microbes Infect (2002) 3.45
Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (2000) 3.26
Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun (1999) 2.92
Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol (2001) 2.63
Factors influencing methicillin resistance in staphylococci. Arch Microbiol (2002) 2.44
Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol (2005) 2.29
Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production. Clin Microbiol Infect (2004) 2.11
Screening for Staphylococcus epidermidis markers discriminating between skin-flora strains and those responsible for infections of joint prostheses. J Infect Dis (2000) 2.09
Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J Infect Dis (2004) 2.09
PCR-Based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains. J Clin Microbiol (2000) 2.05
The ica operon and biofilm production in coagulase-negative Staphylococci associated with carriage and disease in a neonatal intensive care unit. J Clin Microbiol (2002) 1.77
The bacterial insertion sequence element IS256 occurs preferentially in nosocomial Staphylococcus epidermidis isolates: association with biofilm formation and resistance to aminoglycosides. Infect Immun (2004) 1.74
Multiplex PCR assays for the detection of clinically relevant antibiotic resistance genes in staphylococci isolated from patients infected after cardiac surgery. The ESPRIT Trial. J Antimicrob Chemother (2000) 1.58
Assessment of band-based similarity coefficients for automatic type and subtype classification of microbial isolates analyzed by pulsed-field gel electrophoresis. J Clin Microbiol (2005) 1.53
Detection of virulence-associated genes not useful for discriminating between invasive and commensal Staphylococcus epidermidis strains from a bone marrow transplant unit. J Clin Microbiol (2004) 1.52
Inactivations of rsbU and sarA by IS256 represent novel mechanisms of biofilm phenotypic variation in Staphylococcus epidermidis. J Bacteriol (2004) 1.47
Clonal analysis of Staphylococcus epidermidis isolates carrying or lacking biofilm-mediating genes by multilocus sequence typing. J Clin Microbiol (2005) 1.36
Detection of slime production by means of an optimised Congo red agar plate test based on a colourimetric scale in Staphylococcus epidermidis clinical isolates genotyped for ica locus. Biomaterials (2002) 1.34
Reliability of the ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter-related infections. Clin Microbiol Infect (2003) 1.30
Bacterial insertion sequence IS256 as a potential molecular marker to discriminate invasive strains from commensal strains of Staphylococcus epidermidis. J Hosp Infect (2005) 1.19
Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. Int J Med Microbiol (2004) 1.18
Expression of biofilm-associated genes in Staphylococcus epidermidis during in vitro and in vivo foreign body infections. J Infect Dis (2003) 1.06
Coagulase-negative staphylococci in very-low-birth-weight infants: inability of genetic markers to distinguish invasive strains from blood culture contaminants. Eur J Clin Microbiol Infect Dis (2006) 1.03
Phase variation of biofilm formation in Staphylococcus aureus by IS 256 insertion and its impact on the capacity adhering to polyurethane surface. J Korean Med Sci (2004) 1.00
In catheter infections by Staphylococcus epidermidis the intercellular adhesion (ica) locus is a molecular marker of the virulent slime-producing strains. J Biomed Mater Res (2002) 0.87
In vitro and in vivo models of bacterial biofilms. Methods Enzymol (1999) 0.79
Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole. Antimicrob Agents Chemother (1984) 1.61
Late events of translation initiation in bacteria: a kinetic analysis. EMBO J (2000) 1.54
Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. Clin Infect Dis (1999) 1.54
SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes. Microb Drug Resist (2001) 1.35
Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users. J Infect Dis (1997) 1.29
Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS (2000) 1.23
Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy. J Clin Microbiol (1984) 1.21
Pharmacokinetics of fluconazole in normal volunteers. Chemotherapy (1993) 1.10
Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis (1996) 1.02
Pharmacokinetics of sulbactam/ampicillin in humans after intravenous and intramuscular injection. Chemotherapy (1990) 0.99
Characterization of antimicrobial resistance and class 1 integrons in Enterobacteriaceae isolated from Mediterranean herring gulls (Larus cachinnans). Microb Drug Resist (2008) 0.97
In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp. Drugs Exp Clin Res (1987) 0.95
Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin. Chemotherapy (1979) 0.93
Pharmacokinetics of ceforanide. Antimicrob Agents Chemother (1982) 0.93
Antibacterial activity and anti-biofilm effect of chitosan against strains of Streptococcus mutans isolated in dental plaque. Int J Immunopathol Pharmacol (2009) 0.91
Cold-adapted microtubules: characterization of tubulin posttranslational modifications in the Antarctic ciliate Euplotes focardii. Cell Motil Cytoskeleton (1997) 0.89
Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy. Clin Microbiol Infect (2005) 0.88
Pharmacokinetics of cefadroxil after oral administration in humans. Antimicrob Agents Chemother (1982) 0.87
Plasmid curing effect of trovafloxacin. FEMS Microbiol Lett (2000) 0.83
In vitro extracellular and intracellular activity of two newer and two earlier fluoroquinolones against Listeria monocytogenes. Eur J Clin Microbiol Infect Dis (1997) 0.83
Bacteriolytic effect of teicoplanin. J Gen Microbiol (1991) 0.83
Anti-adhesive and pro-apoptotic effects of 2-hydroxyethyl methacrylate on human gingival fibroblasts co-cultured with Streptococcus mitis strains. Int Endod J (2011) 0.83
Consecutive epidemics of Q fever in a residential facility for drug abusers: impact on persons with human immunodeficiency virus infection. Clin Infect Dis (1999) 0.82
[Production of coagulase and thermonuclease in 366 strains of staphylococci belonging to different lyogroups]. Boll Ist Sieroter Milan (1985) 0.81
Antibacterial activity of various antibiotics against oral streptococci isolated in the oral cavity. Int J Immunopathol Pharmacol (2012) 0.81
Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase. J Perinat Med (1989) 0.81
Purpuromycin: an antibiotic inhibiting tRNA aminoacylation. RNA (1997) 0.81
Survey of clinical isolates of Staphylococcus aureus for borderline susceptibility to antistaphylococcal penicillins. Eur J Clin Microbiol Infect Dis (1993) 0.80
A linear model for the pharmacokinetics of azithromycin in healthy volunteers. Chemotherapy (1997) 0.79
In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones. Chemotherapy (1998) 0.79
Rapid desensitization of PC12 cells stimulated with high concentrations of extracellular S100. Neuroscience (1999) 0.79
Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group. J Int Med Res (2000) 0.79
Rapid molecular technique analysis of a KPC-3-producing Klebsiella pneumoniae outbreak in an Italian surgery unit. J Chemother (2012) 0.78
Bacterial and viral DNA in periodontal disease: a study using multiplex PCR. New Microbiol (2004) 0.78
Proopiomelanocortin gene expression and beta-endorphin localization in the pituitary, testis, and epididymis of stallion. Mol Reprod Dev (2006) 0.78
Morphological and functional changes of mitochondria from density separated trout erythrocytes. Biochim Biophys Acta (2000) 0.78
Assessment of the left atrial appendage mechanical function by three-dimensional echocardiography. Eur J Echocardiogr (2002) 0.78
Synthesis of the signal molecule acetylcholine during the developmental cycle of Paramecium primaurelia (Protista, Ciliophora) and its possible function in conjugation. J Exp Biol (2001) 0.77
Wear of dental sealing materials using the replication technique. Eur J Paediatr Dent (2011) 0.77
Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren. J Chemother (2010) 0.77
Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin. Eur J Clin Microbiol Infect Dis (1998) 0.77
Occurrence of Candida species colonization in a population of denture-wearing immigrants. Int J Immunopathol Pharmacol (2013) 0.77
Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia. Clin Cardiol (2001) 0.76
Demineralizing action of EGTA in endodontics. Int J Immunopathol Pharmacol (2007) 0.76
Quantitative assessment of mechanical prosthetic valve area by 3-dimensional transesophageal echocardiography. J Am Soc Echocardiogr (2001) 0.76
Erythrocyte acid phosphatase (ACP1) activity. In vitro modulation by adenosine and inosine and effects of adenosine deaminase (ADA) polymorphism. Hum Genet (1989) 0.76
In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates. J Chemother (2005) 0.76
The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy. Eur J Epidemiol (2000) 0.76
In vitro activity of cefditoren versus other antibiotics against S. pneumoniae clinical strains isolated in Italy. Int J Immunopathol Pharmacol (2010) 0.76
Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy. Eur J Clin Microbiol Infect Dis (2015) 0.75
Identification of the tubulin gene family and sequence determination of one beta-tubulin gene in a cold-poikilotherm protozoan, the antarctic ciliate Euplotes focardii. J Eukaryot Microbiol (1994) 0.75
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. Chemotherapy (2002) 0.75
Red cell and serum polymorphisms in the Oltrepò Pavese population (northern Italy). Gene Geogr (1990) 0.75
Mitochondrial membrane potential in density-separated trout erythrocytes exposed to oxidative stress in vitro. Biochim Biophys Acta (2001) 0.75
[Determining levels of bacteria present in urine by means of a gauged loop (author's transl)]. Quad Sclavo Diagn (1979) 0.75
Serum lysozyme increased by fructose-1, 6-diphosphate in men, rabbits, and mice. J Leukoc Biol (1984) 0.75
Pharmacokinetics of cefatrizine after oral administration in human volunteers. Int J Clin Pharmacol Res (1985) 0.75
[Experimental studies on the antibacterial activity of the association cephaloridine-dicloxacilline (author's transl)]. Ann Sclavo (1977) 0.75
[Study on the antibacterial activity of the combination cefazolin-dicloxacillin]. Nuovi Ann Ig Microbiol (1977) 0.75
Confocal and electron microscopy to characterize sialoglycoconjugates in mouse sublingual gland acinar cells. Eur J Morphol (1998) 0.75
[Antibacterial activity of a carbenicillin-cephaloridin combination]. Ann Sclavo (1976) 0.75
Microbiological and clinical effects of a 1% chlorhexidine-gel in untreated periodontal pockets from adult periodontitis patients. New Microbiol (1999) 0.75
Determination of cefatrizine levels in blood, tonsils, paranasal sinuses and middle ear. Drugs Exp Clin Res (1985) 0.75
Bacteriological and clinical follow-up of periodontal pockets during a topically applied 1% metronidazole-gel therapy in patients with adult periodontitis. New Microbiol (1999) 0.75
A new idea in the field of ACE inhibition: continuous drug administration (perchronotherapy). Boll Chim Farm (1999) 0.75
[Experimental studies of amoxycillin-flucloxacillin combination]. Antibiotica (1974) 0.75
Pharmacokinetics of cefoperazone after single and multiple doses. Int J Clin Pharmacol Res (1986) 0.75
[Lividomycin: microbiological activity in vitro and in vivo]. Ann Sclavo (1974) 0.75
[Efficacy of the carbenicillin-cephaloridine association]. Ann Sclavo (1976) 0.75
[Breast hematoma and cytosteatonecrosis. Apropos of 55 cases]. J Radiol (1990) 0.75
Serum levels and urinary excretion in humans of BL-S 578 (cefadroxil), a new semisynthetic cephalosporin. Chemotherapy (1980) 0.75
A 5'-truncated c-myc gene variant not associated with a risk of cancer. Hum Genet (1991) 0.75
Characterization of a Staphylococcus aureus strain showing high levels of biofilm formation isolated from a vascular graft: case report. Int J Immunopathol Pharmacol (2008) 0.75
Human intravenous and intramuscular pharmacokinetics of amoxicillin. Int J Clin Pharmacol Res (1984) 0.75
[Thrombophlebitis of the right ovarian vein. X-ray computed tomographic diagnosis and monitoring of 2 cases]. J Radiol (1986) 0.75
[Abrikossoff's tumor with bronchial localization. Contribution of x-ray computed tomography in a new case]. J Radiol (1989) 0.75
[Effect of methylpartricine on Trichomonas vaginalis]. Farmaco Prat (1973) 0.75
Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy. Eur J Clin Microbiol Infect Dis (2013) 0.75